Lexeo Therapeutics, Inc. Common Stock
Lexeo Therapeutics, Inc. Common Stock (LXEO) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
lxeo · stock forecast · 5 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 5 Wall Street analysts in the past 3 months
Buy
5 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$25.00
Consensus
$18.33
+336.4% upside
Low
$10.00
Median: $20 · Last Close: $4.20
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Consensus Target
$18.33
336.4% upside
High Target
$25
495.2%
Low Target
$10
138.1%
Current Price
$4.20
as of today
Based on analyst price targets, the LXEO stock price prediction for the next 12 months ranges from $10 to $25. The consensus LXEO price forecast of $18.33 implies 336.4% upside from the current price of $4.20.
Short-Term Price Prediction
BearAlgorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $3.99 | ↓ 5.00% |
1-day model range: $3.94–$4.04. Peak: $4.04 (-5.00%).
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $2 | -42.6% |
| 2028 | $2 | -56.0% |
| 2029 | $2 | -61.7% |
| 2030 | $1 | -64.4% |
| 2031 | — | -65.8% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · LXEO · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-11 | Chardan Capital | Maintains | Buy→Buy |
| 2026-01-13 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-01-13 | Chardan Capital | Maintains | Buy→Buy |
| 2025-12-11 | Chardan Capital | Maintains | Buy→Buy |
| 2025-11-05 | Chardan Capital | Maintains | Buy→Buy |
| 2025-10-21 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-10-07 | Chardan Capital | Maintains | Buy→Buy |
| 2025-10-07 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-10-07 | Leerink Partners | Maintains | Outperform→Outperform |
| 2025-08-15 | HC Wainwright & Co. | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Lexeo Therapeutics, Inc. Common Stock (LXEO) stock. Of the recent 35 rating actions, 0 were upgrades and 0 were downgrades. 5 analysts currently cover LXEO.
Analyst Recommendation Trends
LXEO analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 3 to 1 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$0M
↓ 100.0% YoY
Revenue Next Year
$9M
EPS This Year
$-1.17
EPS Next Year
$-1.26
↑ 7.6% YoY
EPS ForecastReported vs Estimated
Analysts forecast LXEO EPS of $-1.17 for the current fiscal year, based on estimates from 6 analysts. The LXEO revenue forecast is $0M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The LXEO stock forecast is supported by two independent data sources: analyst consensus ratings from 5 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus LXEO price target is $18.33 (+336.4% upside), with an analyst consensus of Buy.
The LXEO short-term stock prediction for tomorrow is $3.99 (-5.00%). The LXEO stock price prediction for 2027 estimates an average of $2. The LXEO stock prediction for 2030 projects a range of $1–$2.
Lexeo Therapeutics, Inc. Common Stock trades on NASDAQ under the ticker LXEO. The LXEO stock outlook for 2027 is broadly positive, supported by a Buy consensus among 100% of covering analysts.
Frequently asked questions
LXEO forecast · 8 questionsAccording to 5 Wall Street analysts, the average 12-month LXEO price target is $18.33, with a high forecast of $25.00 and a low of $10.00. The median price target is shown in the chart above when available. This implies +336.4% potential upside from the current price of $4.20.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.